{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:50:44Z","timestamp":1792795844269,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Friedreich\u2019s ataxia is a rare, progressive, genetic disorder, the root cause of which is a significant deficiency in the mitochondrial protein frataxin. Frataxin is ubiquitously expressed, but its deficiency results in a variety of debilitating symptoms, with disease severity, rate of progression and age of onset inversely correlating with tissue frataxin levels. Nomlabofusp is a novel cell penetrant peptide based recombinant fusion protein designed to enter cells and deliver human FXN into the mitochondria. Using immunofluorescence staining and western blot we show that frataxin delivered by nomlabofusp is detected in the mitochondria of H9c2 and SH-SY5Y cells. Also in these cells, and in C2C12 and HEK293 cells, we demonstrate the presence of mature frataxin after nomlabofusp exposure. Finally, using buccal swab tissue samples taken from study subjects in a Phase 1 clinical trial who received nomlabofusp, we show increases in mature frataxin levels along with marked changes in gene expression post-administration suggesting intracellular pharmacodynamic activity. Together, these results demonstrate that nomlabofusp enters the cell and localizes to the mitochondria, releasing mature frataxin that appears to be biologically active and support the use of nomlabofusp as a potential treatment for patients with Friedreich\u2019s ataxia.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1208\/s12248-025-01054-5","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:27:27Z","timestamp":1743017247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Nomlabofusp, a Fusion Protein of Human Frataxin and a Cell Penetrant Peptide, Delivers Mature and Functional Frataxin into Mitochondria"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2680-1178","authenticated-orcid":false,"given":"Matthew G.","family":"Baile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Sahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7224-1201","authenticated-orcid":false,"given":"Gopi","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"9","key":"1054_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/0883073812448230","volume":"27","author":"MB Delatycki","year":"2012","unstructured":"Delatycki MB, Corben LA. Clinical features of Friedreich ataxia. J Child Neurol. 2012;27(9):1133\u20137. https:\/\/doi.org\/10.1177\/0883073812448230.","journal-title":"J Child Neurol"},{"key":"1054_CR2","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/JMDH.S292945","volume":"14","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Schadt K, Kichula E, McCormack S, Lin KY. Friedreich ataxia: multidisciplinary clinical care. J Multidiscip Healthc. 2021;14:1645\u201358. https:\/\/doi.org\/10.2147\/JMDH.S292945.","journal-title":"J Multidiscip Healthc"},{"issue":"5","key":"1054_CR3","doi-asserted-by":"publisher","first-page":"e63958","DOI":"10.1371\/journal.pone.0063958","volume":"8","author":"HL Plasterer","year":"2013","unstructured":"Plasterer HL, Deutsch EC, Belmonte M, Egan E, Lynch DR, Rusche JR. Development of Frataxin gene expression measures for the evaluation of experimental treatments in Friedreich\u2019s ataxia. PLoS ONE. 2013;8(5):e63958. https:\/\/doi.org\/10.1371\/journal.pone.0063958.","journal-title":"PLoS ONE"},{"issue":"2\u20133","key":"1054_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ymgme.2010.07.001","volume":"101","author":"EC Deutsch","year":"2010","unstructured":"Deutsch EC, Santani AB, Perlman SL, Farmer JM, Stolle CA, Marusich MF, et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab. 2010;101(2\u20133):238\u201345. https:\/\/doi.org\/10.1016\/j.ymgme.2010.07.001.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"1054_CR5","first-page":"1296","volume":"75","author":"M Pandolfo","year":"2008","unstructured":"Pandolfo M. Friedreich ataxia. Arch Neurol. 2008;75(10):1296\u2013303.","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"1054_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.brainresrev.2011.04.001","volume":"67","author":"D Marmolino","year":"2011","unstructured":"Marmolino D. Friedreich\u2019s ataxia: past, present and future. Brain Res Rev. 2011;67(1\u20132):311\u201330. https:\/\/doi.org\/10.1016\/j.brainresrev.2011.04.001.","journal-title":"Brain Res Rev"},{"issue":"11","key":"1054_CR7","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","volume":"6","author":"V Campuzano","year":"1997","unstructured":"Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6(11):1771\u201380. https:\/\/doi.org\/10.1093\/hmg\/6.11.1771.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"1054_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0166-2236(96)20054-2","volume":"19","author":"TJ Gibson","year":"1996","unstructured":"Gibson TJ, Koonin EV, Musco G, Pastore A, Bork P. Friedreich\u2019s ataxia protein: phylogenetic evidence for mitochondrial dysfunction. Trends Neurosci. 1996;19(11):465\u20138. https:\/\/doi.org\/10.1016\/S0166-2236(96)20054-2.","journal-title":"Trends Neurosci"},{"issue":"32","key":"1054_CR9","doi-asserted-by":"publisher","first-page":"22493","DOI":"10.1074\/jbc.M604246200","volume":"281","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Lyver ER, Knight SA, Pain D, Lesuisse E, Dancis A. Mrs3p, Mrs4p, and frataxin provide iron for Fe-S cluster synthesis in mitochondria. J Biol Chem. 2006;281(32):22493\u2013502. https:\/\/doi.org\/10.1074\/jbc.M604246200.","journal-title":"J Biol Chem"},{"issue":"2","key":"1054_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17(2):215\u20137. https:\/\/doi.org\/10.1038\/ng1097-215.","journal-title":"Nat Genet"},{"issue":"1","key":"1054_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0005-2744(80)90274-0","volume":"612","author":"SP Albracht","year":"1980","unstructured":"Albracht SP. The prosthetic groups in succinate dehydrogenase. Number and stoichiometry. Biochim Biophys Acta. 1980;612(1):11\u201328. https:\/\/doi.org\/10.1016\/0005-2744(80)90274-0.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"1054_CR12","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1021\/bi1004798","volume":"49","author":"H Ye","year":"2010","unstructured":"Ye H, Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry. 2010;49(24):4945\u201356. https:\/\/doi.org\/10.1021\/bi1004798.","journal-title":"Biochemistry"},{"issue":"6","key":"1054_CR13","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/mp100223d","volume":"7","author":"D Sarko","year":"2010","unstructured":"Sarko D, Beijer B, Garcia Boy R, Nothelfer E-M, Leotta K, Eisenhut M, et al. The pharmacokinetics of cell-penetrating peptides. Mol Pharm. 2010;7(6):2224\u201331. https:\/\/doi.org\/10.1021\/mp100223d.","journal-title":"Mol Pharm"},{"issue":"3","key":"1054_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/acn3.51971","volume":"11","author":"R Clayton","year":"2024","unstructured":"Clayton R, Galas T, Scherer N, Farmer J, Ruiz N, Hamdani M, et al. Safety, pharmacokinetics, and pharmacodynamics of nomlabofusp (CTI-1601) in Friedreich\u2019s ataxia. Ann Clin Transl Neurol. 2024;11(3):540\u201353. https:\/\/doi.org\/10.1002\/acn3.51971.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"1054_CR15","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/hmg\/ddr554","volume":"21","author":"PM Vyas","year":"2012","unstructured":"Vyas PM, Tomamichel WJ, Pride PM, Babbey CM, Wang Q, Mercier J, et al. A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich\u2019s ataxia mouse model. Hum Mol Genet. 2012;21(6):1230\u201347. https:\/\/doi.org\/10.1093\/hmg\/ddr554.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1054_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1002\/1873-3468.14022","volume":"595","author":"CS Palmer","year":"2021","unstructured":"Palmer CS, Anderson AJ, Stojanovski D. Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer. FEBS Lett. 2021;595(8):1107\u201331. https:\/\/doi.org\/10.1002\/1873-3468.14022.","journal-title":"FEBS Lett"},{"issue":"23","key":"1054_CR17","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1093\/hmg\/ddh324","volume":"13","author":"O Stehling","year":"2004","unstructured":"Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet. 2004;13(23):3007\u201315. https:\/\/doi.org\/10.1093\/hmg\/ddh324.","journal-title":"Hum Mol Genet"},{"key":"1054_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2105-11-94","volume":"11","author":"JH Bullard","year":"2010","unstructured":"Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010;11:94. https:\/\/doi.org\/10.1186\/1471-2105-11-94.","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"1054_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso D, Ngai J, Speed TP, Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32(9):896\u2013902. https:\/\/doi.org\/10.1038\/nbt.2931.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1054_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nm996","volume":"10","author":"JS Wadia","year":"2004","unstructured":"Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med. 2004;10(3):310\u20135. https:\/\/doi.org\/10.1038\/nm996.","journal-title":"Nat Med"},{"issue":"36","key":"1054_CR21","doi-asserted-by":"publisher","first-page":"34141","DOI":"10.1074\/jbc.M303045200","volume":"278","author":"A Fittipaldi","year":"2003","unstructured":"Fittipaldi A, Ferrari A, Zoppe M, Arcangeli C, Pellegrini V, Beltram F, et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem. 2003;278(36):34141\u20139. https:\/\/doi.org\/10.1074\/jbc.M303045200.","journal-title":"J Biol Chem"},{"issue":"2","key":"1054_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/s1525-0016(03)00122-9","volume":"8","author":"A Ferrari","year":"2003","unstructured":"Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giacca M, Beltram F. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther. 2003;8(2):284\u201394. https:\/\/doi.org\/10.1016\/s1525-0016(03)00122-9.","journal-title":"Mol Ther"},{"issue":"15","key":"1054_CR23","doi-asserted-by":"publisher","first-page":"15300","DOI":"10.1074\/jbc.M401604200","volume":"280","author":"JP Richard","year":"2005","unstructured":"Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Chernomordik LV. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem. 2005;280(15):15300\u20136. https:\/\/doi.org\/10.1074\/jbc.M401604200.","journal-title":"J Biol Chem"},{"issue":"25","key":"1054_CR24","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Vives","year":"1997","unstructured":"Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272(25):16010\u20137. https:\/\/doi.org\/10.1074\/jbc.272.25.16010.","journal-title":"J Biol Chem"},{"issue":"11","key":"1054_CR25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dmm.030536","volume":"10","author":"JS Napierala","year":"2017","unstructured":"Napierala JS, Li Y, Lu Y, Lin K, Hauser LA, Lynch DR, et al. Comprehensive analysis of gene expression patterns in Friedreich\u2019s ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers. Dis Model Mech. 2017;10(11):1353\u201369. https:\/\/doi.org\/10.1242\/dmm.030536.","journal-title":"Dis Model Mech"},{"issue":"10","key":"1054_CR26","doi-asserted-by":"publisher","first-page":"e0223209","DOI":"10.1371\/journal.pone.0223209","volume":"14","author":"MZ McMackin","year":"2019","unstructured":"McMackin MZ, Durbin-Johnson B, Napierala M, Napierala JS, Ruiz L, Napoli E, et al. Potential biomarker identification for Friedreich\u2019s ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion. PLoS ONE. 2019;14(10):e0223209. https:\/\/doi.org\/10.1371\/journal.pone.0223209.","journal-title":"PLoS ONE"},{"issue":"3","key":"1054_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ajpath.2013.05.032","volume":"183","author":"ML Huang","year":"2013","unstructured":"Huang ML, Sivagurunathan S, Ting S, Jansson PJ, Austin CJ, Kelly M, et al. Molecular and functional alterations in a mouse cardiac model of Friedreich ataxia: activation of the integrated stress response, eIF2alpha phosphorylation, and the induction of downstream targets. Am J Pathol. 2013;183(3):745\u201357. https:\/\/doi.org\/10.1016\/j.ajpath.2013.05.032.","journal-title":"Am J Pathol"},{"key":"1054_CR28","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","volume":"108","author":"H Derakhshankhah","year":"2018","unstructured":"Derakhshankhah H, Jafari S. Cell penetrating peptides: A concise review with emphasis on biomedical applications. Biomed Pharmacother. 2018;108:1090\u20136. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.097.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1054_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/oxfordjournals.jbchem.a022036","volume":"123","author":"T Omura","year":"1998","unstructured":"Omura T. Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria. J Biochem. 1998;123(6):1010\u20136. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a022036.","journal-title":"J Biochem"},{"issue":"1","key":"1054_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0167-4889(02)00265-3","volume":"1592","author":"O Gakh","year":"2002","unstructured":"Gakh O, Cavadini P, Isaya G. Mitochondrial processing peptidases. Biochim Biophys Acta. 2002;1592(1):63\u201377. https:\/\/doi.org\/10.1016\/s0167-4889(02)00265-3.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1054_CR31","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/s1525-0016(03)00130-8","volume":"7","author":"V Del Gaizo","year":"2003","unstructured":"Del Gaizo V, Payne RM. A novel TAT\u2013Mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther. 2003;7(6):720\u201330. https:\/\/doi.org\/10.1016\/s1525-0016(03)00130-8.","journal-title":"Mol Ther"},{"issue":"6","key":"1054_CR32","doi-asserted-by":"publisher","first-page":"e0129303","DOI":"10.1371\/journal.pone.0129303","volume":"10","author":"AF Branco","year":"2015","unstructured":"Branco AF, Pereira SP, Gonzalez S, Gusev O, Rizvanov AA, Oliveira PJ. Gene expression profiling of H9c2 myoblast differentiation towards a cardiac-like phenotype. PLoS ONE. 2015;10(6):e0129303. https:\/\/doi.org\/10.1371\/journal.pone.0129303.","journal-title":"PLoS ONE"},{"key":"1054_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","volume":"1078","author":"J Kovalevich","year":"2013","unstructured":"Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol. 2013;1078:9\u201321. https:\/\/doi.org\/10.1007\/978-1-62703-640-5_2.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1054_CR34","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.1038\/s41598-024-55516-5","volume":"14","author":"ZB Kaya","year":"2024","unstructured":"Kaya ZB, Santiago-Padilla V, Lim M, Boschen SL, Atilla P, McLean PJ. Optimizing SH-SY5Y cell culture: exploring the beneficial effects of an alternative media supplement on cell proliferation and viability. Sci Rep. 2024;14(1):4775. https:\/\/doi.org\/10.1038\/s41598-024-55516-5.","journal-title":"Sci Rep"},{"issue":"6 Pt 1","key":"1054_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1083\/jcb.127.6.1755","volume":"127","author":"T Katagiri","year":"1994","unstructured":"Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 1994;127(6 Pt 1):1755\u201366. https:\/\/doi.org\/10.1083\/jcb.127.6.1755.","journal-title":"J Cell Biol"},{"issue":"3","key":"1054_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","volume":"51","author":"P Thomas","year":"2005","unstructured":"Thomas P, Smart TG. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods. 2005;51(3):187\u2013200. https:\/\/doi.org\/10.1016\/j.vascn.2004.08.014.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1054_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-1437-2_1","volume":"2311","author":"J Gordon","year":"2021","unstructured":"Gordon J, Amini S. General overview of neuronal cell culture. Methods Mol Biol. 2021;2311:1\u20138. https:\/\/doi.org\/10.1007\/978-1-0716-1437-2_1.","journal-title":"Methods Mol Biol"},{"issue":"8","key":"1054_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/acn3.225","volume":"2","author":"M Lazaropoulos","year":"2015","unstructured":"Lazaropoulos M, Dong Y, Clark E, Greeley NR, Seyer LA, Brigatti KW, et al. Frataxin levels in peripheral tissue in Friedreich ataxia. Ann Clin Transl Neurol. 2015;2(8):831\u201342. https:\/\/doi.org\/10.1002\/acn3.225.","journal-title":"Ann Clin Transl Neurol"},{"issue":"18","key":"1054_CR39","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1073\/pnas.84.18.6364","volume":"84","author":"J Hauber","year":"1987","unstructured":"Hauber J, Perkins A, Heimer EP, Cullen BR. Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci U S A. 1987;84(18):6364\u20138. https:\/\/doi.org\/10.1073\/pnas.84.18.6364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1054_CR40","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/j.1460-2075.1991.tb07697.x","volume":"10","author":"DA Mann","year":"1991","unstructured":"Mann DA, Frankel AD. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 1991;10(7):1733\u20139. https:\/\/doi.org\/10.1002\/j.1460-2075.1991.tb07697.x.","journal-title":"EMBO J"},{"issue":"52","key":"1054_CR41","doi-asserted-by":"publisher","first-page":"41469","DOI":"10.1074\/jbc.M006539200","volume":"275","author":"P Cavadini","year":"2000","unstructured":"Cavadini P, Adamec J, Taroni F, Gakh O, Isaya G. Two-step processing of human frataxin by mitochondrial processing peptidase. Precursor and intermediate forms are cleaved at different rates. J Biol Chem. 2000;275(52):41469\u201375. https:\/\/doi.org\/10.1074\/jbc.M006539200.","journal-title":"J Biol Chem."},{"issue":"2","key":"1054_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, et al. Safety and efficacy of omaveloxolone in Friedreich Ataxia (MOXIe Study). Ann Neurol. 2021;89(2):212\u201325. https:\/\/doi.org\/10.1002\/ana.25934.","journal-title":"Ann Neurol"},{"issue":"17","key":"1054_CR43","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1093\/hmg\/ddy198","volume":"27","author":"D Nachun","year":"2018","unstructured":"Nachun D, Gao F, Isaacs C, Strawser C, Yang Z, Dokuru D, et al. Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich\u2019s ataxia patients. Hum Mol Genet. 2018;27(17):2965\u201377. https:\/\/doi.org\/10.1093\/hmg\/ddy198.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1054_CR44","doi-asserted-by":"publisher","first-page":"e2093","DOI":"10.1002\/mgg3.2093","volume":"11","author":"MB Angulo","year":"2023","unstructured":"Angulo MB, Bertalovitz A, Argenziano MA, Yang J, Patel A, Zesiewicz T, et al. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes. Mol Genet Genomic Med. 2023;11(1):e2093. https:\/\/doi.org\/10.1002\/mgg3.2093.","journal-title":"Mol Genet Genomic Med"},{"issue":"33","key":"1054_CR45","doi-asserted-by":"publisher","first-page":"22968","DOI":"10.1074\/jbc.274.33.22968","volume":"274","author":"A Heddi","year":"1999","unstructured":"Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J Biol Chem. 1999;274(33):22968\u201376. https:\/\/doi.org\/10.1074\/jbc.274.33.22968.","journal-title":"J Biol Chem"},{"issue":"2","key":"1054_CR46","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/febs.13778","volume":"284","author":"M Eisenberg-Bord","year":"2017","unstructured":"Eisenberg-Bord M, Schuldiner M. Ground control to major TOM: mitochondria-nucleus communication. FEBS J. 2017;284(2):196\u2013210. https:\/\/doi.org\/10.1111\/febs.13778.","journal-title":"FEBS J"},{"issue":"2","key":"1054_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neulet.2008.08.065","volume":"445","author":"S Miyata","year":"2008","unstructured":"Miyata S, Mori Y, Tohyama M. PRMT1 and Btg2 regulates neurite outgrowth of Neuro2a cells. Neurosci Lett. 2008;445(2):162\u20135. https:\/\/doi.org\/10.1016\/j.neulet.2008.08.065.","journal-title":"Neurosci Lett"},{"issue":"8","key":"1054_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5483\/BMBRep.2022.55.8.092","volume":"55","author":"SH Kim","year":"2022","unstructured":"Kim SH, Jung IR, Hwang SS. Emerging role of anti-proliferative protein BTG1 and BTG2. BMB Rep. 2022;55(8):380\u20138. https:\/\/doi.org\/10.5483\/BMBRep.2022.55.8.092.","journal-title":"BMB Rep"},{"issue":"37","key":"1054_CR49","doi-asserted-by":"publisher","first-page":"31503","DOI":"10.1074\/jbc.M112.367433","volume":"287","author":"TM Karve","year":"2012","unstructured":"Karve TM, Rosen EM. B-cell translocation gene 2 (BTG2) stimulates cellular antioxidant defenses through the antioxidant transcription factor NFE2L2 in human mammary epithelial cells. J Biol Chem. 2012;287(37):31503\u201314. https:\/\/doi.org\/10.1074\/jbc.M112.367433.","journal-title":"J Biol Chem"},{"key":"1054_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnbeh.2017.00035","volume":"11","author":"F Duclot","year":"2017","unstructured":"Duclot F, Kabbaj M. The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders. Front Behav Neurosci. 2017;11:35. https:\/\/doi.org\/10.3389\/fnbeh.2017.00035.","journal-title":"Front Behav Neurosci"},{"issue":"5","key":"1054_CR51","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ijms21051664","volume":"21","author":"E Havis","year":"2020","unstructured":"Havis E, Duprez D. EGR1 transcription factor is a multifaceted regulator of matrix production in tendons and other connective tissues. Int J Mol Sci. 2020;21(5):1664. https:\/\/doi.org\/10.3390\/ijms21051664.","journal-title":"Int J Mol Sci."},{"key":"1054_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-420170-5.00004-0","volume":"122","author":"A Veyrac","year":"2014","unstructured":"Veyrac A, Besnard A, Caboche J, Davis S, Laroche S. The transcription factor Zif268\/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci. 2014;122:89\u2013129. https:\/\/doi.org\/10.1016\/B978-0-12-420170-5.00004-0.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"13","key":"1054_CR53","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1089\/ars.2012.4537","volume":"19","author":"Y Shan","year":"2013","unstructured":"Shan Y, Schoenfeld RA, Hayashi G, Napoli E, Akiyama T, Iodi Carstens M, et al. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich\u2019s ataxia YG8R mouse model. Antioxid Redox Signal. 2013;19(13):1481\u201393. https:\/\/doi.org\/10.1089\/ars.2012.4537.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1054_CR54","doi-asserted-by":"publisher","first-page":"e10025","DOI":"10.1371\/journal.pone.0010025","volume":"5","author":"D Marmolino","year":"2010","unstructured":"Marmolino D, Manto M, Acquaviva F, Vergara P, Ravella A, Monticelli A, et al. PGC-1alpha down-regulation affects the antioxidant response in Friedreich\u2019s ataxia. PLoS ONE. 2010;5(4):e10025. https:\/\/doi.org\/10.1371\/journal.pone.0010025.","journal-title":"PLoS ONE"},{"key":"1054_CR55","doi-asserted-by":"publisher","first-page":"1289027","DOI":"10.3389\/fnins.2023.1289027","volume":"17","author":"E Indelicato","year":"2023","unstructured":"Indelicato E, Faserl K, Amprosi M, Nachbauer W, Schneider R, Wanschitz J, et al. Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich\u2019s ataxia. Front Neurosci. 2023;17:1289027. https:\/\/doi.org\/10.3389\/fnins.2023.1289027.","journal-title":"Front Neurosci"},{"issue":"7","key":"1054_CR56","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.yexcr.2010.12.023","volume":"317","author":"SH Park","year":"2011","unstructured":"Park SH, Park TJ, Lim IK. Reduction of exportin 6 activity leads to actin accumulation via failure of RanGTP restoration and NTF2 sequestration in the nuclei of senescent cells. Exp Cell Res. 2011;317(7):941\u201354. https:\/\/doi.org\/10.1016\/j.yexcr.2010.12.023.","journal-title":"Exp Cell Res"},{"issue":"7","key":"1054_CR57","doi-asserted-by":"publisher","first-page":"108749","DOI":"10.1016\/j.celrep.2021.108749","volume":"34","author":"C Zhu","year":"2021","unstructured":"Zhu C, Kim SJ, Mooradian A, Wang F, Li Z, Holohan S, et al. Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1. Cell Rep. 2021;34(7):108749. https:\/\/doi.org\/10.1016\/j.celrep.2021.108749.","journal-title":"Cell Rep"},{"key":"1054_CR58","doi-asserted-by":"publisher","first-page":"112310","DOI":"10.1016\/j.intimp.2024.112310","volume":"135","author":"Y Wu","year":"2024","unstructured":"Wu Y, Gou Y, Wang T, Li P, Li Y, Lu X, et al. Exportin XPO6 upregulation activates the TLR2\/MyD88\/NF-kappaB signaling by facilitating TLR2 mRNA nuclear export in COPD pulmonary monocytes. Int Immunopharmacol. 2024;135:112310. https:\/\/doi.org\/10.1016\/j.intimp.2024.112310.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1054_CR59","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/ijms25021261","volume":"25","author":"L Saemann","year":"2024","unstructured":"Saemann L, Wachter K, Georgevici AI, Pohl S, Hoorn F, Veres G, et al. Transcriptomic changes in the myocardium and coronary artery of donation after circulatory death hearts following ex vivo machine perfusion. Int J Mol Sci. 2024;25(2):1261. https:\/\/doi.org\/10.3390\/ijms25021261.","journal-title":"Int J Mol Sci."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01054-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:12:25Z","timestamp":1745817145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01054-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01054-5","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MGB, JJ, NS and GS are employed by Larimar Therapeutics, Inc. and they and\/or their immediate family members may hold company stock or stock options. GS chairs the Larimar Scientific Advisory Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"68"}}